FDA product code LZG: Pump, Infusion, Insulin
LZG is the FDA product code for pump, infusion, insulin. It is a Class II device, regulated under 21 CFR 880.5725 and reviewed by the Clinical Chemistry panel. FDA has cleared 85 510(k) submissions under LZG, 6 in the last five years, from 29 different applicants. The average 510(k) review took 133 days (median 109); 118 days on average over the last three years. FDA has posted 126 recalls for LZG devices, 5 initiated in the last five years.
Classification
| Field | Value |
|---|---|
| Device name | Pump, Infusion, Insulin |
| Device class | Class II |
| Regulation | 21 CFR 880.5725 |
| Review panel | CH — Clinical Chemistry |
| Medical specialty | General Hospital |
| Premarket route | 510(k) |
510(k) clearances per year for LZG
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 1 | 245 |
| 2018 | 1 | 144 |
| 2019 | 2 | 66 |
| 2021 | 1 | 84 |
| 2022 | 1 | 392 |
| 2023 | 1 | 171 |
| 2024 | 2 | 128 |
| 2026 | 2 | 107 |
Compare with all 510(k) review times · Search every LZG clearance
Top LZG applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Medtronic Minimed | 14 | 2024-07-02 |
| Insulet Corporation | 12 | 2023-04-24 |
| Tandem Diabetes Care, Inc. | 7 | 2016-10-25 |
| Animas Corp. | 7 | 2008-06-24 |
| Disetronic Medical Systems AG | 6 | 2006-06-15 |
24 more applicants have LZG clearances. See the full list in Caduvo.
Most recent LZG clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K262153 | Modular Medical, Inc. | Pivot Insulin Delivery System | 2026-09-02 | 68 |
| K253534 | Modular Medical | Pivot Insulin Delivery System | 2026-04-08 | 146 |
| K240158 | Modular Medical, Inc. | Modular Medical MODD1 Insulin Delivery System | 2024-09-04 | 229 |
| K241622 | Medtronic Minimed | Extended Reservoir; MiniMed Reservoir | 2024-07-02 | 27 |
| K223372 | Insulet Corporation | Omnipod GO Insulin Delivery Device | 2023-04-24 | 171 |
Recalls for LZG devices
126 product recalls in 58 recall events; 5 initiated in the last five years and 11 still open. Most recent: 2026-05-20.
| Year | Recalls |
|---|---|
| 2018 | 3 |
| 2019 | 11 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2025 | 1 |
| 2026 | 3 |
HCPCS codes with matching descriptors
Text match between the FDA device name and CMS descriptors, not an official crosswalk:
- A4220 — Refill kit for implantable infusion pump
- E0786 — Implantable programmable infusion pump, replacement (excludes implantable intraspinal catheter)
- E0785 — Implantable intraspinal (epidural/intrathecal) catheter used with implantable infusion pump, replacement
Frequently asked questions
What is FDA product code LZG?
LZG is the FDA product code for pump, infusion, insulin. It is a Class II device, regulated under 21 CFR 880.5725 and reviewed by the Clinical Chemistry panel.
What device class is LZG?
Class II, regulation 21 CFR 880.5725. Typical premarket route: 510(k).
How long does a 510(k) take for product code LZG?
Across 85 cleared submissions the average was 133 days from receipt to decision (median 109).
Which companies have the most LZG clearances?
Medtronic Minimed (14); Insulet Corporation (12); Tandem Diabetes Care, Inc. (7); Animas Corp. (7); Disetronic Medical Systems AG (6).
Have LZG devices been recalled?
Yes: 126 product recalls across 58 recall events; the most recent began 2026-05-20.
Next steps
- Run an FDA pathway report with predicate devices for product code LZG
- Run a recall and safety report across every LZG manufacturer
- Watch product code LZG for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times